Novel Androgen May Be a Potential Candidate for Male Hormonal Contraceptive
11β-MNTDC is a modified testosterone with androgenic and progestational activity that is being developed as a potential male contraceptive.
General Endocrinology
Ovarian Reserve Well Preserved in Transgender Men After 1 Year of Testosterone Therapy
Investigators examined markers of ovarian reserve during testosterone therapy in transgender men.
Genetic Variant May Put Some Women at Increased Risk for Contraception Failure
A genetic variant may play a major role in why hormonal contraception fails in some women, according to a new study published in Obstetrics & Gynecology.
Clinical Outcomes Compared With Generics, Brand-Name Drugs for Chronic Conditions
An analysis of data from over 3.5 million patients found comparable clinical outcomes among patients who initiated generics vs those who were treated with brand-name drugs for chronic conditions such as diabetes, hypertension, osteoporosis, depression and anxiety.
Genetic Predisposition to High Testosterone Levels Linked to Increased Cardiovascular Disease
Men with genetic predisposition to high endogenous testosterone levels might be at greater risk for thromboembolism and heart failure.
Insulin Resistance Does Not Increase Fracture Risk in Patients Without Diabetes
There is no association between insulin resistance and fracture risk in older adults without diabetes.
Managing Venous Thromboembolism in Transgender Women Receiving Hormone Therapy
Transgender women receiving hormone replacement therapy may be at an increased risk for thromboembolism, though data and recommendations vary across studies.
Oral Contraceptive Product Recalled Due to Packaging Error
Apotex announced a voluntary recall of 4 lots of Drospirenone and Ethinyl Estradiol Tablets 3mg/0.03mg due to the possibility of defective blisters with incorrect tablet arrangements and/or empty blister pockets.
Melatonin: Range of Effects and Therapeutic Applications
Along with its effects on the endocrine system, melatonin is involved in regulating certain parameters of the cardiovascular system and central nervous system.
Endocrine Society Objects Changes to Title X Family Planning Program
The Endocrine Society has objected the US Department of Health & Human Services’ update to the Title X Family Planning Program.
Next post in General Endocrinology
